Lv2
186 积分 2023-01-13 加入
Trastuzumab Rezetecan in Human Epidermal Growth Factor Receptor 2-Expressing Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer: A Multicenter, Open-Label, Phase I Trial
12小时前
已完结
Comparison of circulating tumor DNA assays for molecular residual disease detection in non-small cell lung cancer
16天前
已完结
中国抗癌协会男性生殖系统肿瘤专业委员会前列腺癌指南患者版（2025版）
1个月前
已完结
Comparison of gene fusion detection methods in salivary gland tumors
1个月前
已完结
实体瘤常见驱动基因DNA和RNA高通量测序共检专家共识（2025版）
1个月前
已完结
胃肠间质瘤病理诊断临床实践指南（2022版）
1个月前
已完结
Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study
1个月前
已完结
Fibroblast growth factor receptors as treatment targets in clinical oncology
1个月前
已完结
Pemigatinib for Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
1个月前
已完结
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study
1个月前
已完结
皖公网安备34019202002308
